ID: ALA3360919

Max Phase: Preclinical

Molecular Formula: C13H12N4OS4

Molecular Weight: 368.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCSc1nnc(NC(=O)CSc2nc3ccccc3s2)s1

Standard InChI:  InChI=1S/C13H12N4OS4/c1-2-19-13-17-16-11(22-13)15-10(18)7-20-12-14-8-5-3-4-6-9(8)21-12/h3-6H,2,7H2,1H3,(H,15,16,18)

Standard InChI Key:  ZPMIMZUNNFKUQA-UHFFFAOYSA-N

Associated Targets(Human)

Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP 1215 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 368.53Molecular Weight (Monoisotopic): 367.9894AlogP: 3.99#Rotatable Bonds: 6
Polar Surface Area: 67.77Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.84CX Basic pKa: 1.05CX LogP: 4.05CX LogD: 3.46
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.52Np Likeness Score: -3.25

References

1. Hou X, Li R, Li K, Yu X, Sun JP, Fang H..  (2014)  Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening.,  57  (22): [PMID:25372368] [10.1021/jm500692u]

Source